 |
1-[(2-Chloro-4-methoxyphenoxy)methyl]-4-[(2,6-dichlorophenoxy) methyl]benzene |
|---|---|
| Trade Name | |
| Orphan Indication | Poliovirus infection |
| USA Market Approval | USA |
| USA Designation Date | 2012-01-09 00:00:00 |
| Sponsor | ViroDefense, Inc.;155 Gibbs Street, Suite 529;Rockville, Maryland, 20850 |
